title: The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones.
abstract: The histological and ultrastructural effects following 3 weeks' topical treatment with two agents (all-trans retinoic acid and a new synthetic retinoid-like substance, CD271) were evaluated on the epidermis and the epithelial wall of the pseudocomedones in rhino mouse skin. The comedolytic effects of these drugs were similar, and consisted of a reduction of the utricular diameter, with normalization of follicular units. Morphological examinations revealed a hyperplastic response with an increase in the number of cell layers of both epidermis and follicular epithelium, and modifications in keratinocyte differentiation. Ultrastructural changes in the epidermis and epithelial wall were observed mainly in the granular and horny layers, with increased desquamation, and a decrease in the cohesiveness of corneocytes. During the first week of treatment, some cutaneous toxic effects were noticed, but they normalized within two weeks. On the other hand, a fine granular material persisted in the intercellular spaces. It is confirmed that the skin of the rhino mouse is a good model for the evaluation of the comedolytic effects of drugs. Moreover, it reveals the specific effects of retinoids on epidermal differentiation. We have demonstrated that topically applied CD271 induces modifications similar to those obtained with all-trans retinoic acid. It is thus concluded that CD271 is a potentially effective anti-acne agent.
authors.affiliation: Centre International de Recherches Dermatologiques (CIRD), Valbonne, France.
authors.forename: F
authors.initials: F
authors.lastname: Bernerd
authors.forename: J P
authors.initials: JP
authors.lastname: Ortonne
authors.forename: M
authors.initials: M
authors.lastname: Bouclier
authors.forename: A
authors.initials: A
authors.lastname: Chatelus
authors.forename: C
authors.initials: C
authors.lastname: Hensby
mesh_terms: D000068816:Adapalene; D000279:Administration, Cutaneous; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology*; D004195:Disease Models, Animal; D004817:Epidermis / Q000187:drug effects / Q000648:ultrastructure*; D005260:Female; D008297:Male; D051379:Mice; D008812:Mice, Hairless; D008854:Microscopy, Electron; D009281:Naphthalenes / Q000008:administration & dosage / Q000494:pharmacology*; D014212:Tretinoin / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D009281:Naphthalenes; D000068816:Adapalene; D014212:Tretinoin